IL6 and inflammatory bowel disease: In the TNBS model, the therapeutic administration of dexamethasone produced a decrease in pro-inflammatory cytokines similar to that of IBD, such as Tnfa, Il1b1, and Il6, which matched what was observed in the BLI, contrary to an increase in SAA plasmatic levels.